Medical officials say nurse who contracted ebola has been discharged from hospital

The video discusses the discharge of Teresa Romero after 30 days in the hospital, ensuring no risk of contagion post-recovery. It highlights the use of experimental therapies, including hyperimmune syrup and Favipiravir, while acknowledging the lack of a control group. The effectiveness of these treatments remains uncertain, but they offer hope for future patients.

What is the main reason Teresa Romero can be safely discharged from the hospital?

• The virus does not remain in the body after recovery.

• She has been isolated for 30 days.

• She has completed her treatment.

• She has been vaccinated.

Which experimental therapies were used on the patient?

• A hyperimmune syrup and an antiviral called Favipiravir

• A vaccine and a hyperimmune syrup

• An antiviral called Remdesivir and a vaccine

• A hyperimmune syrup and a placebo

Why is there uncertainty about the effectiveness of the therapies used?

• The therapies are new and untested.

• There was no control group in the treatment.

• The patient did not respond to the therapies.

• The therapies were not administered correctly.

What is the significance of not having a control group in the treatment?

• It makes it difficult to determine the effectiveness of the therapies.

• It ensures the patient receives all possible treatments.

• It reduces the cost of treatment.

• It speeds up the recovery process.

What is the future outlook for the therapies used on the patient?

• They are guaranteed to be effective for all patients.

• They will replace all current treatments.

• They are being evaluated for potential use in future patients.

• They will be discontinued due to ineffectiveness.